Skip To Main Content
Timothy M. Uyeki on Muck Rack

Timothy M. Uyeki

As seen in: National Institutes of Health, Emerging Infectious Diseases Journal, Nature, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, Medscape, The New England Journal of Medicine, The Lancet, The World Bank Research Observer, Annals of Internal Medicine and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Timothy M.

Contact Timothy M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Influenza - Nature Reviews Disease Primers

|
By Gabriele Neumann, Benjamin J Cowling, Hualan Chen, Silke Stertz, Balaji Manicassamy, Ian Barr, Timothy M. Uyeki, Yoshihiro Kawaoka
| Nature Verified
Abstract Influenza A and B viruses are considerable public health threats. Annual seasonal epidemics are driven by antigenic drift and cause an estimated 3–5 million severe cases and 290,000–650,000 deaths annually. The clinical presentation of seasonal influenza is typically an abrupt, uncomplicated acute respiratory illness with full recovery; however, it can lead to severe, life-threatening complications in individuals at high risk.
Open in Who Shared Issue with article?
|
By Neha A Sathe, Eric D. Morrell, Ian B. Stanaway, Sarah Holton, Carmen Mikacenic, George L Anesi, Clea R. Barnett, David Brett-Major, M. Broadhurst, Amy Irwin, Vishakha Kumar, Douglas P. Landsittel, Richard Lee, Janice Liebler, Karen Lutrick, Vikramjit Mukherjee, Radu Postelnicu, Leopoldo N Segal, Jonathan E. Sevransky, Avantika Srivastava, Timothy M. Uyeki, David L. Wyles, Laura Evans Verified, Pavan K Bhatraju, Mark M. Wurfel, F. Linzee Mabrey, J. Perren Cobb
| Nature Verified
Abstract Acute respiratory failure (ARF) is common, exhibits variable outcomes, and arises from diverse causes that incompletely reflect underlying biology. Although the pandemic accelerated molecular investigation of ARF in COVID-19, whether these biologic signals generalize to ARF in hospital populations of varying etiology and severity remains unknown.
Open in Who Shared Issue with article?

Plasma proteomics reveals shared biologic signatures of acute respiratory failure across etiology and severity in COVID-19 and non-COVID-19 cohorts

|
By Neha A Sathe, Eric D. Morrell, Ian B. Stanaway, F. Linzee Mabrey, Sarah Holton, Carmen Mikacenic, George L Anesi, Clea R. Barnett, David Brett-Major, M. Broadhurst, J. Perren Cobb, Amy Irwin, Vishakha Kumar, Douglas P. Landsittel, Richard Lee, Janice Liebler, Karen Lutrick, Vikramjit Mukherjee, Radu Postelnicu, Leopoldo N Segal, Jonathan E. Sevransky, Avantika Srivastava, Timothy M. Uyeki, David L. Wyles, Laura Evans Verified, Pavan K Bhatraju, Mark M. Wurfel
| Nature Verified
Abstract Acute respiratory failure (ARF) is common, exhibits variable outcomes, and arises from diverse causes that incompletely reflect underlying biology. Although the pandemic accelerated molecular investigation of ARF in COVID-19, whether these biologic signals generalize to ARF in hospital populations of varying etiology and severity remains unknown.
Open in Who Shared Issue with article?
See all 32 licensed articles (36 Total)